SCHEMBL7185327

SCHEMBL7185327

CCCOc1ccc(C=CC(=O)c2ccc(N)cc2)c(OCCC)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 4/20 0.65
CYP1B1 Q16678 4/20 0.65
CTSL P07711 1/20 0.55
CTSB P07858 1/20 0.55
DPP4 P27487 3/20 0.54
TNFRSF1A P19438 1/20 0.53
ABCG2 Q9UNQ0 2/20 0.53
PTPN1 P18031 2/20 0.49
MAPT P10636 3/20 0.49
LMNA P02545 2/20 0.49
HPGD P15428 1/20 0.49
ALDH1A1 P00352 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
NPY1R P25929 1/20 0.47
NPY2R P49146 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7178752 0.95 CYP1A1 (0.59) CYP1A1CYP1B1CTSLCTSBDPP4
SCHEMBL9113779 0.93 CYP1A1 (0.70) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL9111707 0.90 CYP1A1 (0.67) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL7191470 0.89 ABCG2 (0.67) CYP1A1CYP1B1CTSLCTSBDPP4
SCHEMBL9115209 0.89 CYP1A1 (0.72) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL9113474 0.89 CYP1A1 (0.66) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL7179900 0.88 CYP1A1 (0.64) CYP1A1CYP1B1CTSLCTSBDPP4
SCHEMBL7179904 0.88 CYP1A1 (0.64) CYP1A1CYP1B1CTSLCTSBDPP4
SCHEMBL9115370 0.87 CYP1A1 (0.66) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL7185724 0.86 CYP1A1 (0.62) CYP1A1CYP1B1DPP4TNFRSF1AABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed